US Stock MarketDetailed Quotes
UPB UpStream Bio
- 21.260
- +2.300+12.13%
Close Nov 27 16:00 ET
- 21.260
- 0.0000.00%
Post 16:00 ET
1.14BMarket Cap-16379P/E (TTM)
21.640High18.440Low176.92KVolume18.850Open18.960Pre Close3.65MTurnover1.03%Turnover RatioLossP/E (Static)53.60MShares29.46052wk High-7.11P/B366.74MFloat Cap17.08952wk Low--Dividend TTM17.25MShs Float29.460Historical High--Div YieldTTM16.88%Amplitude17.089Historical Low20.651Avg Price1Lot Size
About UpStream Bio Company
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Company Profile
SymbolUPB
Company NameUpStream Bio
Listing DateOct 11, 2024
Issue Price17.00
Founded2021
CEODr. Everett Rand Sutherland, M.D.
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address890 Winter Street,Suite 200
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-208-2466
Websitehttp://www.upstreambio.com
Company Executives
- Name
- Position
- Salary
- Dr. Everett Rand Sutherland, M.D.
- Chief Executive Officer and Director
- --
- Dr. Adam Houghton, PhD
- Chief Business Officer
- --
- Michael P. Gray
- Chief Financial and Operating Officer
- --
- Dr. Aaron Deykin, M.D.
- Chief Medical Officer and Head of Research and Development
- 823.24K
- Ronald C. Renaud, M.B.A.
- Chairman of the Board
- 208.22K
- Dr. H. Edward Fleming, M.D.
- Independent Director
- --
- Erez Chimovits, M.B.A.,M.Sc.
- Independent Director
- --
- Dr. Marcella Kuhlman Ruddy, M.D.
- Independent Director
- 185.33K
- Dr. Liam Ratcliffe, M.D.,PhD
- Independent Director
- --
- Daniella Beckman
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
